# Study to Evaluate the Efficacy of Two Treatment Schemes With Antivipmyn ® for the Treatment of Snake Bite Envenomation

> **NCT00639951** · PHASE4 · TERMINATED · sponsor: **Instituto Bioclon S.A. de C.V.** · enrollment: 10 (actual)

## Conditions studied

- Snake Bite

## Interventions

- **BIOLOGICAL:** A
- **BIOLOGICAL:** Antivipmyn ®

## Key facts

- **NCT ID:** NCT00639951
- **Lead sponsor:** Instituto Bioclon S.A. de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-03
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Administrative reasons
- **Last updated:** 2016-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00639951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00639951, "Study to Evaluate the Efficacy of Two Treatment Schemes With Antivipmyn ® for the Treatment of Snake Bite Envenomation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00639951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*